CompletedPhase 2NCT00630838

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

Studying Hirschsprung disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Michigan
Principal Investigator: Daniel H Teitelbaum, MD
University of Michigan
Intervention: VSL#3(drug)
Enrollment: 62 enrolled
Eligibility: All sexes
Timeline: 2006 – 2010

Study locations (2)

C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Children's Hospital of Buffalo, Buffalo, New York, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00630838 on ClinicalTrials.gov

Other trials for Hirschsprung disease

Additional recruiting or active studies for the same condition.

See all trials for Hirschsprung disease →

← Back to all trials